Leerink Partners initiated coverage on Tenax Therapeutics with a new price target

10/24/24 6:39:21 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Leerink Partners initiated coverage of Tenax Therapeutics with a rating of Outperform and set a new price target of $16.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TENX

Date	Price Target	Rating	Analyst
10/24/2024	$16.00	Outperform	Leerink Partners
10/14/2024	$16.00	Buy	Guggenheim
9/30/2024		Outperform	William Blair